Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hannah Kim

Showing results (181-190 of 209) with videos related to

Pageof 21
Sort By:
Gynecologic Oncology|April 6, 2024
High throughput screening identifies dasatinib as synergistic with trametinib in low grade serous ovarian carcinomaRobert L Hollis, Richard Elliott, John C Dawson, et al.
NPJ Precision Oncology|June 29, 2022
Molecular characterization of low-grade serous ovarian carcinoma identifies genomic aberrations according to hormone receptor expressionDane Cheasley, Marta Llaurado Fernandez, Martin Köbel, et al.
The Journal of Pathology|May 15, 2026
Identifying therapeutic targets in low-grade serous ovarian carcinomas with no specific molecular profileKathleen I Pishas, Karla J Cowley, Evanny Marinovic, et al.
Journal of the Pediatric Infectious Diseases Society|April 6, 2017
Unique Case of Disseminated Plague With Multifocal OsteomyelitisLeidy Tovar Padua, Amanda Kamali, Hannah Kim, et al.
Gynecologic Oncology|October 18, 2023
Corrigendum to "Low-grade serous carcinoma (LGSC): A Canadian multicenter review of practice patterns and patient outcomes" [Gynecologic Oncology, Volume 157, Issue 1, April 2020, Pages 36-45]Stephanie A Scott, Marta Llaurado Fernandez, Hannah Kim, et al.
The Pediatric Infectious Disease Journal|November 17, 2025
SARS-CoV-2 Infection Versus Vaccination During Pregnancy: Implications for Placental Antibody TransferLeire Perez-Latorre, Shira H Cohen, Pablo J Sánchez, et al.
Cancer Research|January 14, 2021
Multiomics Characterization of Low-Grade Serous Ovarian Carcinoma Identifies Potential Biomarkers of MEK Inhibitor Sensitivity and Therapeutic VulnerabilityRaunak Shrestha, Marta Llaurado Fernandez, Amy Dawson, et al.
Gynecologic Oncology|February 1, 2020
Low-grade serous carcinoma (LGSC): A Canadian multicenter review of practice patterns and patient outcomesStephanie A Scott, Marta Llaurado Fernandez, Hannah Kim, et al.
Korean Journal of Medical Education|June 9, 2022
Impact of medical school responses during the COVID-19 pandemic on student satisfaction: a nationwide survey of US medical studentsIsaac E Kim, Daniel D Kim, Juliana E Kim, et al.
Molecular Cancer Therapeutics|October 5, 2022
NOTCH Signaling Limits the Response of Low-Grade Serous Ovarian Cancers to MEK InhibitionMarta Llaurado Fernandez, E Marielle Hijmans, Annemiek M C Gennissen, et al.
Pageof 21

Showing results (181-190 of 209) with videos related to

Sort By:
Pageof 21
Gynecologic Oncology|April 6, 2024
High throughput screening identifies dasatinib as synergistic with trametinib in low grade serous ovarian carcinomaRobert L Hollis, Richard Elliott, John C Dawson, et al.
NPJ Precision Oncology|June 29, 2022
Molecular characterization of low-grade serous ovarian carcinoma identifies genomic aberrations according to hormone receptor expressionDane Cheasley, Marta Llaurado Fernandez, Martin Köbel, et al.
The Journal of Pathology|May 15, 2026
Identifying therapeutic targets in low-grade serous ovarian carcinomas with no specific molecular profileKathleen I Pishas, Karla J Cowley, Evanny Marinovic, et al.
Journal of the Pediatric Infectious Diseases Society|April 6, 2017
Unique Case of Disseminated Plague With Multifocal OsteomyelitisLeidy Tovar Padua, Amanda Kamali, Hannah Kim, et al.
Gynecologic Oncology|October 18, 2023
Corrigendum to "Low-grade serous carcinoma (LGSC): A Canadian multicenter review of practice patterns and patient outcomes" [Gynecologic Oncology, Volume 157, Issue 1, April 2020, Pages 36-45]Stephanie A Scott, Marta Llaurado Fernandez, Hannah Kim, et al.
The Pediatric Infectious Disease Journal|November 17, 2025
SARS-CoV-2 Infection Versus Vaccination During Pregnancy: Implications for Placental Antibody TransferLeire Perez-Latorre, Shira H Cohen, Pablo J Sánchez, et al.
Cancer Research|January 14, 2021
Multiomics Characterization of Low-Grade Serous Ovarian Carcinoma Identifies Potential Biomarkers of MEK Inhibitor Sensitivity and Therapeutic VulnerabilityRaunak Shrestha, Marta Llaurado Fernandez, Amy Dawson, et al.
Gynecologic Oncology|February 1, 2020
Low-grade serous carcinoma (LGSC): A Canadian multicenter review of practice patterns and patient outcomesStephanie A Scott, Marta Llaurado Fernandez, Hannah Kim, et al.
Korean Journal of Medical Education|June 9, 2022
Impact of medical school responses during the COVID-19 pandemic on student satisfaction: a nationwide survey of US medical studentsIsaac E Kim, Daniel D Kim, Juliana E Kim, et al.
Molecular Cancer Therapeutics|October 5, 2022
NOTCH Signaling Limits the Response of Low-Grade Serous Ovarian Cancers to MEK InhibitionMarta Llaurado Fernandez, E Marielle Hijmans, Annemiek M C Gennissen, et al.
Pageof 21